Anti‐Angiogenic Agents for Advanced Hepatocellular Carcinoma Induce Liver Atrophy
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Medicine"
DOI: 10.1002/cam4.71066
Abstract: Systemic therapy for advanced hepatocellular carcinoma (HCC) includes multi‐kinase inhibitors with anti‐vascular endothelial growth factor (VEGF) activity and anti‐VEGF monoclonal antibodies in combination with immune checkpoint inhibitors. This study aimed to investigate and compare the… read more here.
Keywords: anti angiogenic; agents advanced; angiogenic agents; advanced hepatocellular ... See more keywords